S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Free Trial
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)
Free NAOV Stock Alerts
$0.75
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.75
▼
$0.75
50-Day Range
$0.75
▼
$1.33
52-Week Range
$0.70
▼
$4.34
Volume
3,476 shs
Average Volume
87,618 shs
Market Capitalization
$2.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
NAOV stock logo

About NanoVibronix Stock (NASDAQ:NAOV)

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

NAOV Stock Price History

NAOV Stock News Headlines

April 10, 2024 | investorplace.com
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023
April 9, 2024 | businesswire.com
NanoVibronix Issues Letter to Stockholders
April 19, 2024 | InvestorPlace (Ad)
Now Open: Crypto emergency update
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
March 28, 2024 | finance.yahoo.com
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
February 23, 2024 | benzinga.com
Magnolia Oil & Gas Stock (NYSE:MGY), Quotes and News Summary
February 2, 2024 | uk.finance.yahoo.com
NanoVibronix, Inc. (NAOV)
January 7, 2024 | morningstar.com
NanoVibronix Inc NAOV
December 6, 2023 | finance.yahoo.com
NanoVibronix Featured in Your Bladder Health Magazine
April 19, 2024 | InvestorPlace (Ad)
Now Open: Crypto emergency update
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
December 4, 2023 | finance.yahoo.com
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
November 28, 2023 | markets.businessinsider.com
NanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of Michigan
November 28, 2023 | finance.yahoo.com
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
November 7, 2023 | finance.yahoo.com
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
September 27, 2023 | finanznachrichten.de
NanoVibronix, Inc.: NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff
September 27, 2023 | finance.yahoo.com
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
September 6, 2023 | finance.yahoo.com
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
August 31, 2023 | seekingalpha.com
AMC, MMLP and ARAV among mid-day movers
August 30, 2023 | msn.com
NanoVibronix to raise $5M through private placement
August 30, 2023 | finance.yahoo.com
Why Is NanoVibronix Stock Trading Higher Today?
August 30, 2023 | finance.yahoo.com
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 30, 2023 | investorplace.com
Why Is NanoVibronix (NAOV) Up 153% Today?
August 30, 2023 | finance.yahoo.com
NanoVibronix Cites Positive Results from Independent Testing of UroShield
August 29, 2023 | finance.yahoo.com
NanoVibronix Responds to CMS’ Determination for PainShield
August 28, 2023 | finance.yahoo.com
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
August 23, 2023 | markets.businessinsider.com
NanoVibronix Extends Distribution Deal With UPPI For PainShield, PainShield Plus
August 23, 2023 | finance.yahoo.com
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
June 14, 2023 | finance.yahoo.com
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
See More Headlines
Receive NAOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2018
Today
4/18/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NAOV
CUSIP
N/A
CIK
1326706
Web
www.nanovibronix.com
Phone
(914) 233-3004
Fax
914-376-6111
Employees
9
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($2.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,710,000.00
Net Margins
-162.55%
Pretax Margin
-161.28%
Return on Equity
-123.23%
Return on Assets
-65.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.64
Quick Ratio
1.53

Sales & Book Value

Annual Sales
$2.28 million
Price / Sales
0.91
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.95 per share
Price / Book
0.38

Miscellaneous

Outstanding Shares
2,780,000
Free Float
2,684,000
Market Cap
$2.09 million
Optionable
Not Optionable
Beta
1.25
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Brian M. Murphy (Age 67)
    CEO & Director
    Comp: $342.5k
  • Mr. Stephen R. Brown CPA (Age 68)
    Chief Financial Officer
    Comp: $276.5k
  • Dr. Harold Jacob M.D. (Age 70)
    Chief Medical Officer & Director
  • Mr. Amir Rippel
    Vice President of Marketing
  • Ms. Lindsey Harrison
    Vice President of Sales

Key Competitors

View All Competitors

NAOV Stock Analysis - Frequently Asked Questions

How have NAOV shares performed in 2024?

NanoVibronix's stock was trading at $1.15 at the beginning of 2024. Since then, NAOV stock has decreased by 34.8% and is now trading at $0.75.
View the best growth stocks for 2024 here.

Are investors shorting NanoVibronix?

NanoVibronix saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 2,700 shares, a decrease of 63.0% from the March 15th total of 7,300 shares. Based on an average daily trading volume, of 97,400 shares, the short-interest ratio is presently 0.0 days. Approximately 0.1% of the company's stock are sold short.
View NanoVibronix's Short Interest.

When is NanoVibronix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NAOV earnings forecast.

How were NanoVibronix's earnings last quarter?

NanoVibronix, Inc. (NASDAQ:NAOV) announced its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $0.05 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 123.23% and a negative net margin of 162.55%.

When did NanoVibronix's stock split?

NanoVibronix shares split on the morning of Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were issued to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What other stocks do shareholders of NanoVibronix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and

How do I buy shares of NanoVibronix?

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NAOV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing